NU SKIN ENTERPRISES, INC.

(NUS)
  Report
Delayed Nyse  -  04:00 2022-08-12 pm EDT
45.97 USD   +1.14%
08/08Citigroup Adjusts Price Target on Nu Skin Enterprises to $47 From $45, Maintains Neutral Rating
MT
08/05NU SKIN ENTERPRISES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
08/04NU SKIN : Q2 Earnings Snapshot
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/08/2022 08/09/2022 08/10/2022 08/11/2022 08/12/2022 Date
44.3(c) 43.17(c) 45.2(c) 45.45(c) 45.97(c) Last
329 507 281 811 313 845 323 213 286 550 Volume
+2.19% -2.55% +4.70% +0.55% +1.14% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 2 439 M - -
Net income 2022 172 M - -
Net Debt 2022 - - -
P/E ratio 2022 13,6x
Yield 2022 3,33%
Sales 2023 2 523 M - -
Net income 2023 189 M - -
Net Debt 2023 - - -
P/E ratio 2023 12,1x
Yield 2023 3,35%
Capitalization 2 316 M 2 316 M -
Capi. / Sales 2022 0,95x
Capi. / Sales 2023 0,92x
Nbr of Employees 4 600
Free-Float 55,0%
More Financials
Company
Nu Skin Enterprises, Inc. is a holding company engaged in operating Nu Skin unit. Nu Skin develops and distributes beauty and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands. Nu Skin offers beauty and personal care products that include Body, DR. Dana, Epoch, Nu Colour, Nutricentials, Tri-Phasic White and Tru Face. Pharmanex offers nutritional products, including ageLOC R2,... 
Sector
Personal Products
Calendar
08/25Ex-dividend day for
More about the company
Ratings of Nu Skin Enterprises, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about NU SKIN ENTERPRISES, INC.
08/08Citigroup Adjusts Price Target on Nu Skin Enterprises to $47 From $45, Maintains Neutra..
MT
08/05NU SKIN ENTERPRISES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
AQ
08/04NU SKIN : Q2 Earnings Snapshot
AQ
08/04NU SKIN ENTERPRISES : Q2 2022 Earnings Call Slides
PU
08/04NU SKIN ENTERPRISES : Reports Second Quarter Financial Results - Form 8-K
PU
08/04TRANSCRIPT : Nu Skin Enterprises, Inc., Q2 2022 Earnings Call, Aug 04, 2022
CI
08/04Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Third Quarter and Full Yea..
CI
08/04Earnings Flash (NUS) NU SKIN ENTERPRISES Posts Q2 Revenue $560.6M
MT
08/04Nu Skin Enterprises Reports Second Quarter Financial Results
PR
08/04Nu Skin Enterprises Announces Quarterly Dividend
PR
08/04Nu Skin Enterprises, Inc. Reports Earnings Results for the Second Quarter and Six Month..
CI
08/04Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on September 7, 202..
CI
07/08Levi Strauss, Costco rise; Nu Skin, WD-40 fall
AQ
07/08Jefferies Lowers Price Target for Nu Skin Enterprises to $52 From $60, Maintains Buy Ra..
MT
07/08Nu Skin Enterprises Guides Q2 Revenue Range Below Analyst Consensus; Shares Fall Friday..
MT
More news
News in other languages on NU SKIN ENTERPRISES, INC.
08/04Nu Skin Enterprises, Inc. fournit des prévisions de résultats pour le troisième trimest..
08/04Earnings Flash (NUS) NU SKIN ENTERPRISES affiche un chiffre d'affaires de 560,6 million..
08/04Nu Skin Enterprises, Inc. annonce ses résultats pour le deuxième trimestre et le semest..
08/04Nu Skin Enterprises, Inc. Déclare un dividende trimestriel en espèces, payable le 7 sep..
07/08Les revenus de Nu Skin Enterprises au T2 sont inférieurs au consensus des analystes ; l..
More news
Analyst Recommendations on NU SKIN ENTERPRISES, INC.
More recommendations
Chart NU SKIN ENTERPRISES, INC.
Duration : Period :
Nu Skin Enterprises, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NU SKIN ENTERPRISES, INC.
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 45,97 $
Average target price 48,25 $
Spread / Average Target 4,96%
EPS Revisions
Managers and Directors
Ryan S. Napierski President, Chief Executive Officer & Director
Mark H. Lawrence Chief Financial Officer & Executive Vice President
Steven J. Lund Director
Joseph Y. Chang Chief Scientific Officer & EVP-Product Development
Joe Sueper Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
NU SKIN ENTERPRISES, INC.-9.42%2 316
PROCTER & GAMBLE COMPANY-10.34%350 476
UNILEVER PLC-1.01%120 512
THE ESTÉE LAUDER COMPANIES INC.-25.61%98 406
HINDUSTAN UNILEVER LIMITED9.98%76 583
COLGATE-PALMOLIVE COMPANY-5.92%66 972